Earnings Labs
Liminatus Pharma, Inc. Class A Common Stock logo

Liminatus Pharma, Inc. Class A Common Stock (LIMN) Earnings

NASDAQ·Healthcare·Biotechnology

$0.20

-1.78%

Mkt Cap $6.34M

No upcoming LIMN earnings call has been scheduled. The most recent Liminatus Pharma, Inc. Cl earnings call was last-quarter on Tuesday, March 31, 2026, when EPS came in at -$0.03.

View LIMN earnings dates & history

EPS — Estimate vs Actual

Mkt Cap

$6.34M

P/E

Fwd P/E

P/S

Rev TTM

EPS TTM

-$2.91